Sanfeliu-Cerdán, Neus http://orcid.org/0000-0002-9569-7351
Català-Castro, Frederic
Mateos, Borja
Garcia-Cabau, Carla http://orcid.org/0000-0003-0533-0642
Ribera, Maria
Ruider, Iris
Porta-de-la-Riva, Montserrat http://orcid.org/0000-0002-1514-2883
Canals-Calderón, Adrià
Wieser, Stefan http://orcid.org/0000-0002-2670-2217
Salvatella, Xavier http://orcid.org/0000-0002-8371-4185
Krieg, Michael http://orcid.org/0000-0003-0501-5036
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (715243, 648201)
Human Frontier Science Program
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación
Article History
Received: 22 July 2022
Accepted: 1 September 2023
First Online: 19 October 2023
Competing interests
: X.S. is founder and scientific advisor of Nuage Therapeutics. All other authors declare no competing interests.